跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 320 条关于
“LPAI”
全部
320
临床试验
284
药物
24
机构
3
资讯
9
去年
ZIVO Bioscience Partners with Global Animal Health Leader to Advance Algal-Derived Immune Boosters for Poultry Disease Prevention
去年
Teva's Olanzapine LAI Shows Positive Phase 3 Results for Schizophrenia
去年
Olanzapine LAI Shows Promise in Schizophrenia Treatment with Improved Safety Profile
去年
MedinCell's Olanzapine LAI Phase 3 Trial Completes, Triggering $5M Milestone Payment from Teva
2个月前
Phase 3 SOLARIS Trial: Subcutaneous Olanzapine LAI Demonstrates Efficacy Without PDSS in Schizophrenia
6个月前
Contineum Therapeutics Advances PIPE-791 Phase 2 Trial for Idiopathic Pulmonary Fibrosis with Differentiated LPA1 Receptor Targeting
去年
Sparsentan Demonstrates Efficacy in Treating Genetic FSGS, DUPLEX Trial Analysis Shows
12个月前
Teva's Olanzapine LAI Shows No PDSS Events in 56-Week Phase 3 Trial, Paving Way for First Long-Acting Olanzapine Treatment
22小时前
Teva's Once-Monthly Subcutaneous Olanzapine LAI TEV-'749 Shows High Stabilization and Low Relapse in Phase 3 SOLARIS Post Hoc Data